Edition:
India

Lennox International Inc (LII.N)

LII.N on New York Stock Exchange

204.08USD
23 May 2018
Change (% chg)

$-0.02 (-0.01%)
Prev Close
$204.10
Open
$202.92
Day's High
$204.47
Day's Low
$202.92
Volume
14,278
Avg. Vol
95,167
52-wk High
$222.31
52-wk Low
$160.18

Select another date:

Mon, Apr 23 2018

BRIEF-Lennox International Says CEO's 2017 Compensation Was $11.45 Mln

* LENNOX INTERNATIONAL INC SAYS CEO TODD M. BLUEDORN'S 2017 TOTAL COMPENSATION WAS $11.45 MILLION VERSUS $10 MILLION IN 2016 – SEC FILING‍​ Source: (https://bit.ly/2GUhs6F) Further company coverage:

BRIEF-Lennox International Q4 EPS $1.02 From Continuing Operations

* LENNOX INTERNATIONAL REPORTS RECORD FOURTH QUARTER MARGIN AND PROFIT TO CAP RECORD YEAR AND RAISES 2018 EPS GUIDANCE FOR U.S. TAX LEGISLATION

BRIEF-Ovid Therapeutics Announces TAK-935/OV935 Granted Orphan Drug Designation By U.S. FDA For Treatment Of Lennox-Gastaut Syndrome

* OVID THERAPEUTICS ANNOUNCES TAK-935/OV935 GRANTED ORPHAN DRUG DESIGNATION BY U.S. FDA FOR TREATMENT OF LENNOX-GASTAUT SYNDROME

BRIEF-Lennox International Sees Fy18 Revenue Up 3 To 7 Percent

* REAFFIRMS FY 2017 ADJUSTED EARNINGS PER SHARE VIEW $7.75 TO $8.05 FROM CONTINUING OPERATIONS

Select another date: